Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol plus metformin versus megestrol plus placebo for endometrial hyperplasia
IRCT20140820018866N6Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in endometrial hyperplasia (EH) comparing Megestrol + placebo with Megestrol + metformin (2 arms). Primary endpoints: Endometrial thickness and Uterine bleeding. Started Nov 2015; status: completed.
02
Drugs
megestrolmetformin
03
Conditions
endometrial hyperplasia (EH)
Beyond the preview
Go deeper on IRCT20140820018866N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140820018866N6.